resveratrol has been researched along with Thyroid Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 6 (35.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Allah, WH; Aboumanei, MH; Mahmoud, AF; Sakr, TM; Swidan, MM | 1 |
| Du, Z; Li, Y; Zhang, J; Zhou, H | 1 |
| Li, H; Li, S; Li, TT; Liu, J; Lu, MD; Nie, JH; Wu, ML; Ye, HS | 1 |
| Li, PN; Li, YT; Liu, J; Liu, YS; Tian, XT; Wu, J; Wu, ML | 1 |
| Armanini, D; Barollo, S; Fokou, PVT; López, MD; Martorell, M; Pezzani, R; Rajabi, S; Ribaudo, G; Sharifi-Rad, J; Toro, MT; Zagotto, G | 1 |
| Bian, P; Hu, W; Li, L; Liu, C | 1 |
| Allegri, L; Baldan, F; Damante, G; Filetti, S; Mio, C; Rosignolo, F | 1 |
| Cheng, XX; Kong, QY; Li, H; Li, YT; Liu, J; Tian, XT; Wu, ML; Zheng, X; Zhu, GW | 1 |
| Choi, KC; Hwang, KA; Shin, HJ | 1 |
| Ahmed, K; Chen, H; Harrison, AD; Jaskula-Sztul, R; Kunnimalaiyaan, M; Yu, XM | 1 |
| Chen, H; Chen, J; Hardin, H; Harrison, AD; Larrain, C; Lloyd, RV; Yu, XM; Zhang, R | 1 |
| Morris, JC | 1 |
| Chen, H; Cook, MR; Kunnimalaiyaan, M; Pinchot, SN; Truong, M | 1 |
| Hong, MK; Kang, HJ; Kim, LS; Youn, YK | 1 |
| Duntas, LH | 1 |
| Clark, OH; Park, JW | 1 |
| Davis, FB; Davis, PJ; Lin, HY; Shih, A | 1 |
5 review(s) available for resveratrol and Thyroid Neoplasms
| Article | Year |
|---|---|
Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review).
Topics: Cell Line, Tumor; Humans; Phytochemicals; Resveratrol; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2022 |
Plant natural products with anti-thyroid cancer activity.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Clinical Trials as Topic; Curcumin; Humans; Isoflavones; Molecular Structure; Phytochemicals; Quercetin; Resveratrol; Thyroid Neoplasms | 2020 |
Antitumor Effect of Various Phytochemicals on Diverse Types of Thyroid Cancers.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Curcumin; Disease Models, Animal; Humans; Isoflavones; Phytochemicals; Resveratrol; Thyroid Carcinoma, Anaplastic; Thyroid Gland; Thyroid Neoplasms | 2019 |
Resveratrol and its impact on aging and thyroid function.
Topics: Adenocarcinoma, Follicular; Aging; Humans; Mitogen-Activated Protein Kinases; Phosphotransferases (Alcohol Group Acceptor); Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Thyroid Gland; Thyroid Neoplasms; Thyrotropin; Tumor Suppressor Protein p53 | 2011 |
Redifferentiation therapy for thyroid cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Transformation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phenylacetates; Phenylbutyrates; Receptors, Cytoplasmic and Nuclear; Resveratrol; Retinoids; Stilbenes; Thyroid Neoplasms; Transcription Factors | 2004 |
12 other study(ies) available for resveratrol and Thyroid Neoplasms
| Article | Year |
|---|---|
New frontier radioiodinated probe based on in silico resveratrol repositioning for microtubules dynamic targeting.
Topics: Animals; Drug Repositioning; Iodine Radioisotopes; Mice; Microtubules; Resveratrol; Thyroid Neoplasms | 2023 |
Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations.
Topics: Humans; Mutation; Proto-Oncogene Proteins B-raf; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2022 |
STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
Topics: Antioxidants; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Leukemia Inhibitory Factor; Phosphorylation; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2020 |
Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Mice, Inbred BALB C; Mice, Nude; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Sirolimus; Thyroid Cancer, Papillary; Thyroid Neoplasms; TOR Serine-Threonine Kinases | 2020 |
Effects of nutraceuticals on anaplastic thyroid cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Curcumin; Dietary Supplements; Genistein; Humans; MicroRNAs; Resveratrol; Stilbenes; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2018 |
Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells.
Topics: Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Resveratrol; Stilbenes; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tretinoin; Up-Regulation | 2018 |
Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.
Topics: Animals; Anticarcinogenic Agents; Antigens, Differentiation; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Random Allocation; Receptor, Notch1; Resveratrol; Signal Transduction; Stilbenes; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2013 |
Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid.
Topics: Animals; Antioxidants; Blotting, Western; Cell Culture Techniques; Cell Line, Tumor; Enzyme Inhibitors; Flow Cytometry; Heterografts; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Valproic Acid | 2016 |
Resveratrol, thyroid cancer, and iodide: drink up?
Topics: Animals; Humans; Iodides; Rats; Resveratrol; Stilbenes; Symporters; Thyroid Gland; Thyroid Neoplasms | 2010 |
Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Blotting, Western; Carcinoma, Medullary; Caspase 3; Cell Line, Tumor; Cell Proliferation; Chromogranin A; Humans; Neurosecretory Systems; Poly(ADP-ribose) Polymerases; Receptor, Notch2; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Thyroid Neoplasms | 2011 |
Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals.
Topics: Antigens, CD; Antineoplastic Agents; Carcinoma, Embryonal; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Flavonoids; Gene Expression Regulation, Neoplastic; Genistein; Humans; Kaempferols; Models, Biological; Phenols; Polyphenols; Quercetin; Receptors, G-Protein-Coupled; Resorcinols; Resveratrol; Stilbenes; Symporters; Thyroid Neoplasms | 2011 |
Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Papillary; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Resveratrol; RNA, Messenger; Stilbenes; Thyroid Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |